© 2020 MJH Life Sciences and HCPLive. All rights reserved.
December 05, 2012
Combining the investigational PD 0332991 with letrozole as first-line therapy extended progression-free survival in women with advanced estrogen-receptor positive breast cancer.
Extending the duration of adjuvant tamoxifen treatment to 10 years was more effective than the standard 5 years of treatment in protecting against recurrence and death among women with ER+ breast cancer.
March 04, 2011
Two studies presented at SABCS refined knowledge about how to prevent lymphedema in patients with breast cancer.